Signaling Pathways - Myosin light chain kinases (MLCKs) - CREBBP - Topoisomerases - P110
清除全部
-
B4745 (S)-10-Hydroxycamptothecin中文名: 羟喜树碱Target: TopoisomerasesSummary: 拓扑异构酶I抑制剂 -
B6342 H-7 dihydrochlorideTarget: PKC|PKG|PKA|Myosin light chain kinases (MLCKs)Summary: 蛋白激酶抑制剂 -
B7382 Ellipticine中文名: 玫瑰树碱，椭圆玫瑰树碱Target: TopoisomerasesSummary: DNA拓扑异构酶II抑制剂 -
B3523 Fasudil中文名: 法舒地尔Target: ROCK|PKC|PKG|PKA|Myosin light chain kinases (MLCKs)Summary: 钙拮抗剂 -
B2295 Pirarubicin1 Citation中文名: 吡柔比星Target: TopoisomerasesSummary: 拓扑异构酶II抑制剂，蒽环类抗生素 -
B1801 Norfloxacin中文名: 诺氟沙星Target: TopoisomerasesSummary: 拓扑异构酶抑制剂 -
B2293 Irinotecan HCl Trihydrate中文名: 盐酸依立替康三水合物Target: TopoisomerasesSummary: 拓扑异构酶I抑制剂 -
B2172 PP121Target: mTOR|Eph Receptors|VEGFR|PDGFR|Bcr-Abl|Src|DNA-PK|P110|HckSummary: 酪氨酸激酶和磷酸肌醇激酶双重抑制剂 -
B2290 Beta-Lapachone中文名: β-拉帕醌Target: TopoisomerasesSummary: 选择性DNA拓扑异构酶I抑制剂 -
A8400 Clinafloxacin CI96 AM1091中文名: 克林沙星Target: TopoisomerasesSummary: 拓扑异构酶抑制剂